Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia

Diabetes mellitus termed as metabolic disorder is a collection of interlinked diseases and mainly body’s inability to manage glucose level which leads to cardiovascular diseases, renal failure, neurological disorders, and many others. The drugs contemporarily used for diabetes have many inevitable s...

Full description

Bibliographic Details
Main Authors: Rawaba Arif, Sajjad Ahmad, Ghulam Mustafa, Hafiza Salaha Mahrosh, Muhammad Ali, Muhammad Tahir ul Qamar, Hafiza Rabia Dar
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2021/5561129
id doaj-a8a6254654c14fc6afba90e217ffb11f
record_format Article
spelling doaj-a8a6254654c14fc6afba90e217ffb11f2021-10-04T01:58:11ZengHindawi LimitedBioMed Research International2314-61412021-01-01202110.1155/2021/5561129Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantiaRawaba Arif0Sajjad Ahmad1Ghulam Mustafa2Hafiza Salaha Mahrosh3Muhammad Ali4Muhammad Tahir ul Qamar5Hafiza Rabia Dar6Department of BiochemistryDepartment of Health and Biological SciencesDepartment of BiochemistryDepartment of BiochemistryDepartment of BiotechnologyCollege of Life Science and TechnologyDepartment of BiochemistryDiabetes mellitus termed as metabolic disorder is a collection of interlinked diseases and mainly body’s inability to manage glucose level which leads to cardiovascular diseases, renal failure, neurological disorders, and many others. The drugs contemporarily used for diabetes have many inevitable side effects, and many of them have become less responsive to this multifactorial disorder. Momordica charantia commonly known as bitter gourd has many bioactive compounds with antidiabetic properties. The current study was designed to use computational methods to discover the best antidiabetic peptides devised from hypoglycemic polypeptide-P of M. charantia. The binding affinity and interaction patterns of peptides were evaluated against four receptor proteins (i.e., as agonists of insulin receptor and inhibitors of sodium-glucose cotransporter 1, dipeptidyl peptidase-IV, and glucose transporter 2) using molecular docking approach. A total of thirty-seven peptides were docked against these receptors. Out of which, top five peptides against each receptor were shortlisted based on their S-scores and binding affinities. Finally, the eight best ligands (i.e., LIVA, TSEP, EKAI, LKHA, EALF, VAEK, DFGAS, and EPGGGG) were selected as these ligands strictly followed Lipinski’s rule of five and exhibited good ADMET profiling. One peptide EPGGGG showed activity towards insulin and SGLT1 receptor proteins. The top complex for both these targets was subjected to 50 ns of molecular dynamics simulations and MM-GBSA binding energy test that concluded both complexes as highly stable, and the intermolecular interactions were dominated by van der Waals and electrostatic energies. Overall, the selected ligands strongly fulfilled the drug-like evaluation criterion and proved to have good antidiabetic properties.http://dx.doi.org/10.1155/2021/5561129
collection DOAJ
language English
format Article
sources DOAJ
author Rawaba Arif
Sajjad Ahmad
Ghulam Mustafa
Hafiza Salaha Mahrosh
Muhammad Ali
Muhammad Tahir ul Qamar
Hafiza Rabia Dar
spellingShingle Rawaba Arif
Sajjad Ahmad
Ghulam Mustafa
Hafiza Salaha Mahrosh
Muhammad Ali
Muhammad Tahir ul Qamar
Hafiza Rabia Dar
Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
BioMed Research International
author_facet Rawaba Arif
Sajjad Ahmad
Ghulam Mustafa
Hafiza Salaha Mahrosh
Muhammad Ali
Muhammad Tahir ul Qamar
Hafiza Rabia Dar
author_sort Rawaba Arif
title Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
title_short Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
title_full Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
title_fullStr Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
title_full_unstemmed Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
title_sort molecular docking and simulation studies of antidiabetic agents devised from hypoglycemic polypeptide-p of momordica charantia
publisher Hindawi Limited
series BioMed Research International
issn 2314-6141
publishDate 2021-01-01
description Diabetes mellitus termed as metabolic disorder is a collection of interlinked diseases and mainly body’s inability to manage glucose level which leads to cardiovascular diseases, renal failure, neurological disorders, and many others. The drugs contemporarily used for diabetes have many inevitable side effects, and many of them have become less responsive to this multifactorial disorder. Momordica charantia commonly known as bitter gourd has many bioactive compounds with antidiabetic properties. The current study was designed to use computational methods to discover the best antidiabetic peptides devised from hypoglycemic polypeptide-P of M. charantia. The binding affinity and interaction patterns of peptides were evaluated against four receptor proteins (i.e., as agonists of insulin receptor and inhibitors of sodium-glucose cotransporter 1, dipeptidyl peptidase-IV, and glucose transporter 2) using molecular docking approach. A total of thirty-seven peptides were docked against these receptors. Out of which, top five peptides against each receptor were shortlisted based on their S-scores and binding affinities. Finally, the eight best ligands (i.e., LIVA, TSEP, EKAI, LKHA, EALF, VAEK, DFGAS, and EPGGGG) were selected as these ligands strictly followed Lipinski’s rule of five and exhibited good ADMET profiling. One peptide EPGGGG showed activity towards insulin and SGLT1 receptor proteins. The top complex for both these targets was subjected to 50 ns of molecular dynamics simulations and MM-GBSA binding energy test that concluded both complexes as highly stable, and the intermolecular interactions were dominated by van der Waals and electrostatic energies. Overall, the selected ligands strongly fulfilled the drug-like evaluation criterion and proved to have good antidiabetic properties.
url http://dx.doi.org/10.1155/2021/5561129
work_keys_str_mv AT rawabaarif moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
AT sajjadahmad moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
AT ghulammustafa moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
AT hafizasalahamahrosh moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
AT muhammadali moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
AT muhammadtahirulqamar moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
AT hafizarabiadar moleculardockingandsimulationstudiesofantidiabeticagentsdevisedfromhypoglycemicpolypeptidepofmomordicacharantia
_version_ 1716844758749413376